SCHEMBL4790423

SCHEMBL4790423

Cc1ccc(-c2c(C(NC(=O)O)C(C)(C)C)c(CC(C)C)nc3ccc(C4CC4C(N)=O)cc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3906102 0.82 DPP4 (0.54) DPP4
Hydrochloric Acid SCHEMBL3890597 0.82 DPP4 (0.69) DPP4
SCHEMBL4790425 0.81 DPP4 (0.51) DPP4
Hydrochloric Acid SCHEMBL3895138 0.76 DPP4 (0.68) DPP4
SCHEMBL4705946 0.75 DPP4 (0.46) DPP4
SCHEMBL3896099 0.74 DPP4 (0.42) DPP4
Hydrochloric Acid SCHEMBL3890634 0.74 DPP4 (0.54) DPP4
SCHEMBL3903756 0.74 DPP4 (0.47) DPP4
Hydrochloric Acid SCHEMBL3899188 0.73 DPP4 (0.63) DPP4
SCHEMBL3895213 0.71 DPP4 (0.44) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1527049-B8 FUSED HETEROCYCLIC COMPOUNDS AS PEPTIDASE INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2008-10-29 EP disclosed
EP-1527049-A2 FUSED HETEROCYCLIC COMPOUNDS AS PEPTIDASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2005-05-04 EP disclosed
WO-2004014860-A2 FUSED HETEROCYCLIC COMPOUNDS AS PEPTIDASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 WO disclosed